
Join to View Full Profile
1120 NW 14th StreetMiami, FL 33136
Dr. Coffey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2012 - 2015
- University of ColoradoResidency, Internal Medicine, 2009 - 2012
- University of Colorado School of Medicine Anschutz Medical CampusClass of 2009, MD
- Tulane UniversityBS, Biology, 1999 - 2003
Certifications & Licensure
- FL State Medical License 2021 - 2026
- WA State Medical License 2012 - 2022
- CO State Medical License 2009 - 2012
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Outcomes and treatment patterns in primary and secondary plasma cell leukemia: insights from a large US cohort study.Shagun Singh, Supriya Peshin, Betsy C Wertheim, Ashley Larsen, Iloabueke Chineke
Haematologica. 2025-04-17 - A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-up.Sherilyn A Tuazon, Andrew J Portuguese, Margot J Pont, Andrew J Cowan, Gabriel O Cole
Blood. 2025-04-08 - Individualized dynamic risk assessment and treatment selection for multiple myeloma.Carl Murie, Serdar Turkarslan, Anoop P Patel, David G Coffey, Pamela S Becker
British Journal of Cancer. 2025-04-01
Journal Articles
- FAS ligand gene transfer for cancer therapyJaime F Modiano, Angela R Lamerato-Kozicki, CM Jubala, David G Coffey, Michelle Borakove, Jerome Schaack, and Donald Bellgrau, Cancer Therapy
Abstracts/Posters
- Efficacy and Safety of Fully Human Bcma CAR T Cells in Combination with a Gamma Secretase Inhibitor to Increase Bcma Surface Expression in Patients with Relapsed or Re...David G. Coffey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Targeted Next Generation Sequencing of Circulating Tumor DNA in Multiple MyelomaCoffey DG, Orneals S, Towlerton AMH, Warren EH, Blood 2017 130:4337, American Society of Hematology Annual Meeting, 2017
- Simultaneous Detection Of Single Nucleotide Variants, mRNA Transcripts, And Protein Expression In Myeloma Bone Marrow AspiratesCoffey DG, Lombardo KA, Towlerton AMH, Farwell MA, Meredith G, Meredith R, Green DJ, Warren EH, Blood 2017 130:1758, American Society of Hematology Annual Meeting, 2017
- Join now to see all
Lectures
- High-Throughput Functional Drug Screening and Genomic Analysis to Guide Individualized Therapy for Relapsed/Refractory Multiple Myeloma61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Reduced Antigen Presentation May Contribute to Immunomodulatory Drug Resistance in Multiple Myeloma61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
- Mission Bio and University of Miami Collaborate on Multiple Myeloma ResearchDecember 2nd, 2024
- Mission Bio Announces Partnership to Advance Multiple Myeloma InsightsDecember 2nd, 2024
- Mission Bio Partners with Top Researchers from University of Miami to Accelerate Early Relapse Detection & Treatment Selection of Multiple Myeloma PatientsDecember 2nd, 2024
- Join now to see all
Grant Support
- Data Generation and Bioinformatics Support GrantSeattle Translational Tumor Research2019–2020
- Catalytic Collaboration Pilot AwardBrotman Baty Institute2019
- Research Training Award for FellowsAmerican Society of Hematology2015–2016
- T32 FellowshipNational, Heart, Lung and Blood Institute2014–2015
Professional Memberships
- Member
- Society for Immunotherapy of CancerMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: